在急性缺血性中风中nerinetide的治疗潜力:一个全面的系统审查和元分析
Vikash Kumar1, Muhammad Mohsin Zahoor2, Fnu Simran3
1Department of Internal Medicine, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
Annals of medicine and surgery (2012)
|January 7, 2026
概括
涅利尼提德可能会降低急性缺血性中风 (AIS) 患者的死亡率,特别是那些没有接受阿尔特的患者. 虽然功能恢复没有得到改善,但它的安全性概况需要进一步研究神经保护.
科学领域:
- 神经科学是一个神经科学.
- 心血管医学 心血管医学
- 临床试验 临床试验
背景情况:
- 急性缺血性中风 (AIS) 是全球主要的死亡和残疾原因.
- 尼利尼提德是一种神经保护性,在限制中风后的神经元损伤方面表现有前途.
- 早期服用涅利尼提德对于其潜在的治疗效果至关重要.
研究的目的:
- 在AIS患者中,评估nerinetide与安慰剂的疗效和安全性.
- 评估内利尼提德对死亡率和功能恢复的影响.
- 分析与涅利尼提德治疗相关的不良事件.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 搜索了主要的数据库 (PubMed,MEDLINE,Cochrane等等) 在2025年2月之前.
- 主要结局:死亡率;次要结局:功能恢复,心脏病发作量,不良事件.
主要成果:
- 包括3个RCT,包括2462名患者.
- 涅利尼提德显示,死亡风险的统计显著降低 (RR=0.86,P=0.05).
- 功能恢复或心脏病发作大小没有显著改善;不良事件与安慰剂相比.
结论:
- 涅利尼提德可能在AIS中提供轻微的死亡益处,特别是在非alteplase治疗的患者中.
- 尽管没有功能性改善,但nerinetide的安全概况支持进一步的研究.
- 建议进行更大规模的临床试验,以确认内瑞尼提德的神经保护潜力.
相关概念视频
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.3K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K
Antianginal Drugs: Nitrates and β-Blockers
1.4K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
915
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
915
Ischemic Heart Disease: Overview
2.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.8K


